Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies—PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice
Stefania Tognin,Hendrika H van Hell,Kate Merritt,Inge Winter-van Rossum,Matthijs G Bossong,Matthew J Kempton,Gemma Modinos,Paolo Fusar-Poli,Andrea Mechelli,Paola Dazzan,Arija Maat,Lieuwe de Haan,Benedicto Crespo-Facorro,Birte Glenthøj,Stephen M Lawrie,Colm McDonald,Oliver Gruber,Therese van Amelsvoort,Celso Arango,Tilo Kircher,Barnaby Nelson,Silvana Galderisi,Rodrigo Bressan,Jun S Kwon,Mark Weiser,Romina Mizrahi,Gabriele Sachs,Anke Maatz,René Kahn,Phillip McGuire,Philip McGuire,Stefania Tognin,Paolo Fusar-Poli,Matthew Kempton,Gemma Modinos,Kate Merritt,Andrea Mechelli,Paola Dazzan,George Gifford,Natalia Petros,Mathilde Antoniades,Andrea De Micheli,Sandra Vieira,Tom J Spencer,Cristina Scarpazza,Emily Hird,Rene Kahn,Arija Maat,Erika van Hell,Inge Winter,Wiepke Cahn,Hugo Schnack,Lieuwe de Haan,Dieuwke Siegmann,Jana Barkhof,Lotte Hendriks,Iris de Wit,Benedicto Crespo-Facorro,Diana Tordesillas-Gutierrez,Esther Setien-Suero,Rosa Ayesa-Arriola,Paula Suarez-Pinilla,MariaLuz Ramirez-Bonilla,Victor Ortiz Garcia-de la foz,Birte Glenthøj,Mikkel Erlang Sørensen,Karen Tangmose,Helle Schæbel,Brian Broberg,Egill Rostrup,Stephen Lawrie,Colm McDonald,Brian Hallahan,Dara Cannon,James McLoughlin,Martha Finnegan,Oliver Gruber,Therese van Amelsvoort,Danny Deckers,Machteld Marcelis,Claudia Vingerhoets,Celso Arango,Covadonga M Díaz-Caneja,Miriam Ayora,Joost Janssen,Roberto Rodríguez-Jiménez,Marina Díaz-Marsá,Tilo Kircher,Irina Falkenberg,Florian Bitsch,Philipp Berger,Jens Sommer,Kyeon Raab,Babette Jakobi,Barnaby Nelson,Patrick McGorry,Paul Amminger,Meredith McHugh,Silvana Galderisi,Armida Mucci,Paola Bucci,Giuseppe Piegari,Daria Pietrafesa,Alessia Nicita,Sara Patriarca,Rodrigo Bressan,André Zugman,Ary Gadelha,Graccielle Rodrigues da Cunha,Jun Soo Kwon,Kang I k Kevin Cho,Tae Young Lee,Minah Kim,Yoo Bin Kwak,Wu Jeong Hwang,Mark Weiser,Romina Mizrahi,Michael Kiang,Cory Gerritsen,Margaret Maheandiran,Sarah Ahmed,Ivana Prce,Jenny Lepock,Gabriele Sachs,Matthäus Willeit,Marzena Lenczowski,Ullrich Sauerzopf,Ana Weidenauer,Julia Furtner-Srajer,Matthias Kirschner,Anke Maatz,Achim Burrer,Philipp Stämpfli,Naemi Huber,Stefan Kaiser,Wolfram Kawohl,Michael Brammer,Jonathan Young,Edward Bullmore,Sarah Morgan,
DOI: https://doi.org/10.1093/schbul/sbz067
2019-08-19
Schizophrenia Bulletin
Abstract:Abstract In the last 2 decades, several neuroimaging studies investigated brain abnormalities associated with the early stages of psychosis in the hope that these could aid the prediction of onset and clinical outcome. Despite advancements in the field, neuroimaging has yet to deliver. This is in part explained by the use of univariate analytical techniques, small samples and lack of statistical power, lack of external validation of potential biomarkers, and lack of integration of nonimaging measures (eg, genetic, clinical, cognitive data). PSYSCAN is an international, longitudinal, multicenter study on the early stages of psychosis which uses machine learning techniques to analyze imaging, clinical, cognitive, and biological data with the aim of facilitating the prediction of psychosis onset and outcome. In this article, we provide an overview of the PSYSCAN protocol and we discuss benefits and methodological challenges of large multicenter studies that employ neuroimaging measures.
psychiatry